Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,714 | 40,486 | 16,456 | 9,749 | 479 |
| Marketable Securities | 23,062 | N/A | N/A | N/A | N/A |
| Receivables | 86 | 27 | N/A | N/A | 245 |
| Other current assets | 174 | 48 | 29 | 87 | 146 |
| TOTAL | $85,215 | $42,303 | $18,476 | $9,836 | $869 |
| Non-Current Assets | |||||
| PPE Net | 20 | 6 | 1 | N/A | 3 |
| Investments And Advances | 0 | 4,919 | 0 | 0 | 0 |
| Intangibles | 799 | 799 | 799 | 799 | 0 |
| Other Non-Current Assets | 712 | 85 | 2,798 | 3,902 | 17,764 |
| TOTAL | $1,532 | $5,809 | $3,598 | $4,702 | $17,767 |
| Total Assets | $86,747 | $48,112 | $22,074 | $14,537 | $18,636 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,992 | 4,955 | 1,241 | 729 | 704 |
| Accrued Expenses | 702 | 533 | 145 | N/A | N/A |
| Other current liabilities | N/A | N/A | N/A | N/A | 535 |
| TOTAL | $5,121 | $6,317 | $2,216 | $1,606 | $3,294 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 65 | 2,479 | 3,295 | 16,131 |
| Deferred Revenues | 152 | 152 | 152 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 8,110 | 36 | 4,576 |
| TOTAL | $1,524 | $1,741 | $4,308 | $3,295 | $20,706 |
| Total Liabilities | $6,645 | $8,058 | $6,524 | $4,901 | $24,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,544 | 34,374 | 25,821 | 5,067 | 46 |
| Common Shares | 45 | 34 | 26 | 5 | 121 |
| Retained earnings | -95,185 | -39,404 | -18,926 | -853 | -61,310 |
| Other shareholders' equity | -234 | -234 | -85 | 12 | 16 |
| TOTAL | $80,102 | $40,055 | $15,550 | $9,636 | $-5,364 |
| Total Liabilities And Equity | $86,747 | $48,112 | $22,074 | $14,537 | $18,636 |